Increased Th1 and Th2 type cytokine production in patients with active tuberculosis

Israel Medical Association Journal

Volumn 9, Issue 6, 2007, Pages 479-483

  Handzel, Zeev T ^a,g   Barak, Vivian ^b   Altman, Yehudith ^a,g   Bibi, Haim ^c   Lidgi, Moshe ^d   Iancovici Kidon, Mona ^a,g   Yassky, Dov ^e   Raz, Meir ^f  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d Tel Aviv University Sackler Faculty of Medicine   (Israel)

^e Data Acquisition and Analysis   (Israel)

^f MACCABI HEALTHCARE SERVICES   (Israel)

^g HEBREW UNIVERSITY   (Israel)

Author keywords

Cytokines T cells; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; ISONIAZID; TUBERCULIN; TUBERCULOSTATIC AGENT;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EASTERN EUROPE; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; HUMAN; IMMIGRANT; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROBABILITY; SUPERNATANT; TH1 CELL; TH2 CELL; TUBERCULIN TEST; TUBERCULOSIS;

CASE-CONTROL STUDIES; CYTOKINES; EMIGRATION AND IMMIGRATION; ETHIOPIA; EUROPE, EASTERN; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; ISRAEL; MYCOBACTERIUM TUBERCULOSIS; SEVERITY OF ILLNESS INDEX; TH1 CELLS; TH2 CELLS; TUBERCULOSIS;

EID: 34250818090     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. World Health Organization. Tuberculosis. Fact Sheet No.104, WHO (http://www.who.org), 2000.
2. Andersen P. TB vaccines: progress and problems. Trends Immunol 2001;22:160.
3. Chemtob D, Lebenthal A, Weiler-Ravell D. Tuberculosis in the world and in Israel - main epidemiological aspects. Harefuah 2002;141:226-32 (Hebrew).
4. Kori M, Barak V, Leibovitz E, Altman Y, Eliraz A, Handzel ZT. Specific in vitro proliferative immune responses and lymphokine production in Ethiopian children with and without tuberculosis. Infection 2000;28:42-5.
5. Flynn JAL, Chan J. Immunology of tuberculosis. Ann Rev Immunol 2001;19:93-129.
6. Demangel C, Britton WJ. Interaction of dendritic cells with mycobacteria: where the action starts. Immunol Cell Biol 2000;78:318-24.
7. Vilcek J, Klion A, Henriksen-DeStefano D, et al. Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis. J Clin Immunol 1986;6:146-51.
8. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nature Genet 1999;21:370-8.
9. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-5.
10. Gollob JA, Veenstra KG, Jyonouchi H, et al. Impairment of STAT activation by IL-12 in a patient with atypical mycobacterial and staphylococcal infections. J Immunol 2000;165:4120-6.
11. Bentwich Z. Good worms or bad worms: do worm infections affect the epidemiological pattern of other diseases? Parasitol Today 2000;16:312.
12. Van Crevel R, Karyadi E, Preyers F, et al. increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000;181:1194-7.
13. Infante-Duarte C, Kamradt T. Th1/Th2 balance in infection. Semin Immunopathol 1999;21:317-38.
14. Saunders BM, Frank AA, Orme IM, Cooper AM. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 2000;68:3322-6.
15. Bussiotis VA, Tsai EY, Yunis EJ, et al. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-25.
16. Jacobs M, Brown N, Allie N, Gulert R, Ryffel B. increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 2000;100:494-501.
17. Saunders BM, Frank AA, Orme IM. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 1999;98:324-8.
18. Bussiotis VA, Tsai EY, Yunis EJ, et al. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-25.
19. Tiemessen CT, Shalekoff S, Maddows-Taylor S, Martin DJ. Anti-tuberculous treatment: increasing evidence for drug effects on innate immunity. Clin Diagn Lab Immunol 2001;8:686-9.
20. Bughdadi JE, Orlova M, Alter A, et al. An autosomal dominant major gene confers predisposition to pulmonary tuberculosis in adults. J Exp Med 2006;203:1679-84.